Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome
about
BMI1: A Biomarker of Hematologic MalignanciesGenetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndromeMicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythrodermaMolecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell linesMalignant inflammation in cutaneous T-cell lymphoma-a hostile takeoverExogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells.Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions.Sézary Syndrome: Clinical and Biological Aspects.The biomarker landscape in mycosis fungoides and Sézary syndrome.Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders.Diagnosis and classification of hematologic malignancies on the basis of genetics.Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.Role of dysregulated cytokine signaling and bacterial triggers in the pathogenesis of Cutaneous T Cell Lymphoma.Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis-like T-cell lymphoma.Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).FISH Panel for Leukemic CTCL.Different genetic alteration of A20 in a Sézary syndrome case with Vα2-Jα22 T cell clone.A retrospective comparative outcome analysis following systemic therapy in Mycosis fungoides and Sezary syndrome.STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma.Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation.Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms.Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
P2860
Q26750676-0A6EEB93-7266-4907-B7C2-4559ECA7B642Q33889309-0AA039CC-DE44-4593-B7E0-C7553F52C975Q34545956-093007B5-EE90-44C7-9D0F-E036C76AEFECQ36310531-B418D8B0-27AE-42EE-9935-4C05F81BA1B8Q36372043-871BABD5-FF6A-495B-8817-7AE33883B1DCQ37723390-4FBE2B5D-0CB2-425B-8D29-1690801E1400Q38727148-5EADF38A-3D2D-4CB8-98CF-0E95C11D6CC8Q38765889-90B3675C-4DD2-4088-B1D1-A4183F710FA8Q38805440-05BBE28D-5FB9-4E05-96DC-58FCAC3A7EFDQ38814744-9F2834FC-1F02-467E-9751-3751466549D0Q39023382-5CFB95A1-C626-4C47-9D40-64E3435F00BEQ39055861-91F97CE4-3E0F-4EBA-A912-300E6DFADE34Q39363409-398BB82D-A522-4878-AD00-3E7BEE4E5FDBQ47133172-E4F528CD-4861-49D4-872A-4C4345731401Q47359072-8E3F36C8-3E10-458A-933E-602691908673Q47613529-5304F593-66D0-4988-AE8A-B07D2082B45BQ48128019-4D3F5A38-002F-444B-8ECB-736FD5A0702DQ48149767-2449CE63-5118-4CB9-840A-D3AC85457B48Q50330301-CB177D66-010A-4A31-9C62-5349BAA5710CQ51098387-8DA25EA8-943D-45F6-AE7F-61135DBD80A0Q51484852-14A12062-E203-476D-8F98-2079AD1B9B26Q54959839-D3BF8204-A43B-4F9C-9C31-ADFB346FE767Q55116387-88A8A102-03CE-48DD-A142-70E92D21C729Q55356840-8CE3135E-62CE-4B1A-8A79-82B7543DE754Q58742961-32A56688-71AB-4780-BDC7-B6A16D38E82C
P2860
Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Genomic analyses reveal recurr ...... TAT pathway in Sézary syndrome
@en
type
label
Genomic analyses reveal recurr ...... TAT pathway in Sézary syndrome
@en
prefLabel
Genomic analyses reveal recurr ...... TAT pathway in Sézary syndrome
@en
P2093
P2860
P50
P356
P1476
Genomic analyses reveal recurr ...... TAT pathway in Sézary syndrome
@en
P2093
Anagh A Sahasrabuddhe
Bryan L Betz
David W Bahler
Delphine C M Rolland
Fuzon Chung
John C Byrd
L Jeffrey Medeiros
Mark J Kiel
Matthew Schaller
Roberto N Miranda
P2860
P2888
P356
10.1038/NCOMMS9470
P407
P577
2015-09-29T00:00:00Z